Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

China flag China · Delayed Price · Currency is CNY
233.00
+7.75 (3.44%)
Feb 28, 2025, 4:00 PM CST
96.36%
Market Cap 86.22B
Revenue (ttm) 5.82B
Net Income (ttm) 3.60B
Shares Out 401.00M
EPS (ttm) 9.12
PE Ratio 23.57
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,489,069
Average Volume 1,601,377
Open 226.38
Previous Close 225.25
Day's Range 219.50 - 235.60
52-Week Range 106.03 - 246.31
Beta 1.29
RSI 73.04
Earnings Date Mar 29, 2025

About SHA:688506

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China. [Read more]

Sector Healthcare
Founded 2006
Employees 2,086
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688506
Full Company Profile

Financial Performance

In 2023, SHA:688506's revenue was 561.87 million, a decrease of -20.11% compared to the previous year's 703.28 million. Losses were -780.50 million, 176.4% more than in 2022.

Financial Statements

News

There is no news available yet.